Ksi.To
KSI provides software solutions for the healthcare industry, focusing on clinical information systems and related services.
Business. KSI provides software solutions for the healthcare industry, focusing on clinical information systems and related services.
Analyst recommendations
6 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Peers
- EarningsQ2 2026 earnings (expected)2026-07-28 · estimated · ServiceNow (NOW)
- EarningsQ2 2026 earnings (expected)2026-08-28 · estimated · Salesforce (CRM)
- Macro
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
- Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
- Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
KSI provides software solutions for the healthcare industry, focusing on clinical information systems and related services.
KSI's capital structure shows a debt-to-equity ratio of 0.44, indicating a relatively conservative leverage position compared to industry norms. The company's liquidity is assessed as medium, with a current ratio of 1.82, suggesting it can cover its short-term obligations but with limited excess capacity. However, the company's free cash flow is negative at -10,385,830 CAD, and its operating cash flow is 12,260,950 CAD, indicating that capital expenditures are outpacing operating cash generation.
Profitability metrics show a return on equity of -3.61% and a return on assets of -1.93%, both of which are negative and significantly below the industry median for software companies. This suggests that KSI is not generating returns that meet the cost of capital for either equity or total assets.
KSI's revenue is concentrated in the healthcare technology segment, with no disclosed geographic diversification in the provided data. The company's exposure to a single industry and lack of geographic spread could increase its vulnerability to sector-specific downturns or regulatory changes.
The company's growth trajectory is mixed. While it has a negative operating income of -8,446,880 CAD and a net loss of -2,348,650 CAD, the outlook for the current fiscal year suggests a potential improvement in revenue. However, the exact numeric delta for the next fiscal year is not provided in the data.
Risk factors include a medium liquidity risk due to the negative free cash flow and a key flag indicating that net cash is negative after subtracting total debt. The dilution risk is assessed as low, with no near-term pressure expected. The company has not made any recent significant announcements or filings that would suggest a change in its strategic direction or financial position.
Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company's recent performance and outlook suggest that it is in a period of transition or investment, which may affect its short-term profitability but could support long-term growth.
- KSI has a conservative debt-to-equity ratio of 0.44, indicating a relatively low leverage position.
- The company's return on equity and return on assets are negative, suggesting poor profitability.
- KSI's free cash flow is negative, indicating that capital expenditures are outpacing operating cash generation.
- The company's growth trajectory is mixed, with a potential improvement in revenue for the current fiscal year.
- KSI faces medium liquidity risk and low dilution risk, with no near-term pressure expected.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,06 |
| Revenue | —no estimate | —no estimate | 78,0M CAD |
| Operating income | —no estimate | —no estimate | -6,9M CAD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- KSI.TO Market data — financials · 2026-05-28
- Kneat.com Inc Market data — analyst estimates · 2026-05-28